Despite the extensive evidence that elevated IL-17 occurs in certain endotypes of asthma (e.g., neutrophilic), multiple clinical trials of targeting a reduction in IL-17 have not been successful [34,35,36,37]. The gene discussed is IL17A; the disease is asthma.